Records containing: Major Depressive Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-04-29A Multi-center, Open-label Trial to Assess the Long-term Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2024-04-26AN OPEN-LABEL STUDY OF ALTO-300 IN ADULTS WITH MAJOR DEPRESSIVE DISORDER
-
CLINICAL_TRIALS study record update · 2024-04-24Model-based Defining of Subtypes of Depression and Optimal Treatment: an Integrated Techniques Module in Multidimensional Omics for Peripheral Biomarkers.
-
CLINICAL_TRIALS study record update · 2024-04-23Spinal Cord Stimulation for the Treatment of Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2024-04-19The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density - A Single Dose Randomized, Double Blind, Placebo- Controlled Phase 2 Positron Emission Tomography Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-04-18A Randomized Clinical Trial of Response to Psychopharmacotherapy According to Multimodal Serum Biomarkers in Depressive Patients
-
CLINICAL_TRIALS study record update · 2024-04-18The Efficacy and Safety of Xiongdan Wan on Patients With Major Depressive Disorder : a Single-arm, Non-randomized, Open-label Trial
-
CLINICAL_TRIALS study record update · 2024-04-15Unraveling the Aesthetic Mind in Anhedonia, Insights From Pharmacological Imaging of the Human Brain: A Single-blind, Randomized, Placebo-controlled Cross-over Study
-
CLINICAL_TRIALS study record update · 2024-04-10Feasibility and Effectiveness of Delivering Cognitive Behaviour Therapy Through Online Psychotherapy Tool (OPTT) for Depression
-
CLINICAL_TRIALS study record update · 2024-04-10Getting Out of the House: A Behavioral Activation Approach to Support Community Participation With Individuals With Serious Mental Illness
-
CLINICAL_TRIALS study record update · 2024-04-10Investigating the Effectiveness of Incorporating a Stepped Care Approach Into Electronically-delivered CBT for Depression
-
CLINICAL_TRIALS study record update · 2024-04-05Self-guided Treatment for Adolescents/Adults Navigating Depression (STAND-MDD): A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-04-04Investigating Biological Markers, Targets, and Intervention for Mood Disorders
-
CLINICAL_TRIALS study record update · 2024-04-03TBS Treatment for Treatment-Resistant Depression: a Randomized, Sham-Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-04-03Brain Oscillation Synchronized Stimulation of the Frontal Cortex: Randomized Controlled Trial Comparing Frontal Theta-oscillation Synchronized Repetitive TMS With Standard TMS in Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2024-04-02Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)
-
CLINICAL_TRIALS study record update · 2024-04-02Mini Theta Burst TMS to Promote Brain Plasticity Indexed by fMRI in MDD Patients
-
CLINICAL_TRIALS study record update · 2024-04-01An Open-label, Adaptive Design Study in Healthy Male Participants to Characterize the Occupancy of NR2B Subunit Containing NMDA Receptors in the Brain Following a Single Intravenous Dose of MIJ821 Using Positron Emission Tomography (PET) With the Radioligand [11C]Me-NB1
-
CLINICAL_TRIALS study record update · 2024-04-01Agomelatine Augmentation in Early-Nonresponsive Patients With Major Depressive Disorder Receiving SSRIs or SNRIs: a Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial
-
CLINICAL_TRIALS study record update · 2024-03-27A Double-blind, Randomised, Placebo-controlled Study of Intravenous Doses of SPL026 (DMT Fumarate), a Serotonergic Psychedelic, in Healthy Subjects (Part A) and Patients With Major Depressive Disorder (Part B)
-
CLINICAL_TRIALS study record update · 2024-03-26A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment of Major Depressive Disorder (The RELIANCE-I Study)
-
CLINICAL_TRIALS study record update · 2024-03-26A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of REL-1017 Monotherapy for Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2024-03-26Exploring Blood Plasma Metabolomics: Unraveling the Metabolic Landscape in Treatment-Resistant Adolescent Depression
-
CLINICAL_TRIALS study record update · 2024-03-26The Relationship Between Emotion Regulation and Psychiatric Disorder in Youth - From a Psychosocial Developmental Aspect.
-
CLINICAL_TRIALS study record update · 2024-03-25A Phase I/IIa, Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Relative Bioavailability and Food Effect Cohort to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of CYB003 in Healthy Participants With and Without Major Depressive Disorder (MDD)